IQVIA Pharma Deals Review of 2024
By Lucy Haggerty,Taskin Ahmed,Ayush Saxena & Shikha Kashyap
Pharma Deals Review: Vol 2025 Issue 3 (Table of Contents)
Published: 21 Mar-2025
DOI: 10.3833/pdr.v2025.i3.2936 ISSN: 1756-7874
Section: Opinion & Analysis
Fulltext:
Abstract
After a sluggish 2023, the slowdown in deal activity in the life sciences sector continued in 2024 as persistent macroeconomic headwinds discouraged companies from signing M&A, licensing and collaborative R&D deals over the course of the year...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS